ATE319455T1 - Vitamin d-verbindungen zur behandlung von chronischer tranplantatnephropathie bei nieren transplantieren patienten - Google Patents
Vitamin d-verbindungen zur behandlung von chronischer tranplantatnephropathie bei nieren transplantieren patientenInfo
- Publication number
- ATE319455T1 ATE319455T1 AT01920583T AT01920583T ATE319455T1 AT E319455 T1 ATE319455 T1 AT E319455T1 AT 01920583 T AT01920583 T AT 01920583T AT 01920583 T AT01920583 T AT 01920583T AT E319455 T1 ATE319455 T1 AT E319455T1
- Authority
- AT
- Austria
- Prior art keywords
- transplant
- vitamin
- tenephropathy
- compounds
- treatment
- Prior art date
Links
- 210000003734 kidney Anatomy 0.000 title abstract 2
- 230000001684 chronic effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 229940088594 vitamin Drugs 0.000 title 1
- 229930003231 vitamin Natural products 0.000 title 1
- 235000013343 vitamin Nutrition 0.000 title 1
- 239000011782 vitamin Substances 0.000 title 1
- 150000003722 vitamin derivatives Chemical class 0.000 title 1
- 230000003907 kidney function Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 229930003316 Vitamin D Natural products 0.000 abstract 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 abstract 1
- 238000002650 immunosuppressive therapy Methods 0.000 abstract 1
- 230000000087 stabilizing effect Effects 0.000 abstract 1
- 235000019166 vitamin D Nutrition 0.000 abstract 1
- 239000011710 vitamin D Substances 0.000 abstract 1
- -1 vitamin D compound Chemical class 0.000 abstract 1
- 229940046008 vitamin d Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- External Artificial Organs (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19264900P | 2000-03-27 | 2000-03-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE319455T1 true ATE319455T1 (de) | 2006-03-15 |
Family
ID=22710501
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01920583T ATE319455T1 (de) | 2000-03-27 | 2001-03-20 | Vitamin d-verbindungen zur behandlung von chronischer tranplantatnephropathie bei nieren transplantieren patienten |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1267886B1 (de) |
| JP (1) | JP2003528833A (de) |
| AT (1) | ATE319455T1 (de) |
| AU (1) | AU2001247619A1 (de) |
| CA (1) | CA2404335C (de) |
| DE (1) | DE60117762T2 (de) |
| DK (1) | DK1267886T3 (de) |
| ES (1) | ES2255548T3 (de) |
| NZ (1) | NZ521923A (de) |
| PT (1) | PT1267886E (de) |
| WO (1) | WO2001072292A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2317992C2 (ru) | 2003-02-25 | 2008-02-27 | Кей Эн Си Лэборэтериз Ко., Лтд. | Новые промежуточные соединения для синтеза производных витамина d |
| WO2011017165A1 (en) * | 2009-08-03 | 2011-02-10 | Wisconsin Alumni Research Foundation | Method of preventing renal disease and treating symptoms thereof |
| RU2666995C2 (ru) | 2012-06-29 | 2018-09-13 | Висконсин Алюмни Рисерч Фаундейшн | ПРИМЕНЕНИЕ 2-МЕТИЛЕН-19-НОР-(20S)-1α,25-ДИГИДРОКСИВИТАМИНА D3 ДЛЯ ЛЕЧЕНИЯ ВТОРИЧНОГО ГИПЕРПАРАТИРЕОЗА |
| US10369161B2 (en) | 2014-12-30 | 2019-08-06 | Wisconsin Alumni Research Foundation | Use of 2-methylene-19-NOR-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat primary hyperparathyroidism |
| US9539264B2 (en) | 2014-12-30 | 2017-01-10 | Wisconsin Alumni Research Foundation | Use of 2-methylene-19-nor-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism in patients previously treated with calcimimetics |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2270373A1 (en) * | 1996-10-31 | 1998-05-07 | American Home Products Corporation | Synergistic composition comprising rapamycin and calcitriol |
| DE69826285T2 (de) * | 1997-06-06 | 2005-10-20 | Wisconsin Alumni Research Foundation, Madison | Verwendung von vitamin d verbindungen zur vorbeugung von transplantatabstossung |
| JP4219553B2 (ja) * | 1997-09-08 | 2009-02-04 | エフ．ホフマン−ラ ロシュ アーゲー | １，３−ジヒドロキシ−２０，２０−ジアルキル−ビタミンｄ３類似体 |
| GB9721156D0 (en) * | 1997-10-06 | 1997-12-03 | Leo Pharm Prod Ltd | Novel vitamin d analogues |
-
2001
- 2001-03-20 EP EP01920583A patent/EP1267886B1/de not_active Expired - Lifetime
- 2001-03-20 PT PT01920583T patent/PT1267886E/pt unknown
- 2001-03-20 ES ES01920583T patent/ES2255548T3/es not_active Expired - Lifetime
- 2001-03-20 DK DK01920583T patent/DK1267886T3/da active
- 2001-03-20 AT AT01920583T patent/ATE319455T1/de active
- 2001-03-20 NZ NZ521923A patent/NZ521923A/en not_active IP Right Cessation
- 2001-03-20 AU AU2001247619A patent/AU2001247619A1/en not_active Abandoned
- 2001-03-20 WO PCT/US2001/008939 patent/WO2001072292A2/en not_active Ceased
- 2001-03-20 DE DE60117762T patent/DE60117762T2/de not_active Expired - Lifetime
- 2001-03-20 JP JP2001570253A patent/JP2003528833A/ja active Pending
- 2001-03-20 CA CA002404335A patent/CA2404335C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| PT1267886E (pt) | 2006-05-31 |
| EP1267886B1 (de) | 2006-03-08 |
| JP2003528833A (ja) | 2003-09-30 |
| AU2001247619A1 (en) | 2001-10-08 |
| WO2001072292A2 (en) | 2001-10-04 |
| WO2001072292A3 (en) | 2002-05-16 |
| CA2404335C (en) | 2009-01-06 |
| NZ521923A (en) | 2004-11-26 |
| ES2255548T3 (es) | 2006-07-01 |
| DE60117762T2 (de) | 2006-10-12 |
| EP1267886A2 (de) | 2003-01-02 |
| DE60117762D1 (de) | 2006-05-04 |
| DK1267886T3 (da) | 2006-07-10 |
| CA2404335A1 (en) | 2001-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1150738T3 (da) | Implantat | |
| BR0316487A (pt) | Método todo de tratamento da rejeição de transplantes | |
| ATE292971T1 (de) | (s,s)-reboxetin zur behandlung von peripheren neuropathien | |
| DE60118604D1 (de) | Photosensibilisator-enthaltende lagerungslösung zur inaktivierung von biologischen verunreinigungen | |
| DK1318992T3 (da) | Imidazolderivater som Raf-kinaseinhibitorer | |
| WO2005027993A3 (en) | Vascular access preservation in hemodialysis patients | |
| BRPI0417803A (pt) | método de tratamento de rejeição de transplantes | |
| ATE410430T1 (de) | 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose | |
| DE60139466D1 (de) | Behandlung von diabetes | |
| DE69116380D1 (de) | Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit | |
| DE60105025D1 (de) | Pharmazeutische verbindungen zur behandlung von chronisch-obstruktiver bronchopneumonie | |
| DE50010284D1 (de) | Arzneimittel zur behandlung von bluthochdruck | |
| EA200700407A1 (ru) | Производные хиназолина и их использования при лечении тромбоцитемии | |
| ATE319455T1 (de) | Vitamin d-verbindungen zur behandlung von chronischer tranplantatnephropathie bei nieren transplantieren patienten | |
| EA200200853A1 (ru) | Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака | |
| DE50111407D1 (de) | Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen | |
| MY117746A (en) | Blood pressure stabilization during hemodialysis | |
| ATE486594T1 (de) | Methode zur behandlung von herzinsuffizienz | |
| ATE392213T1 (de) | Verwendung von gamma-gt inhibitoren zur behandlung von chronischen degenerativerkrankungen | |
| WO2003039231A3 (en) | Compounds and methods for treating transplant rejection | |
| ATE297745T1 (de) | Chemische modifizierung von harn von säugern |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1267886 Country of ref document: EP |